232 related articles for article (PubMed ID: 33569319)
1. MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer.
Zhao S; Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Ding L; Mao L; Wu N
Transl Lung Cancer Res; 2021 Jan; 10(1):368-380. PubMed ID: 33569319
[TBL] [Abstract][Full Text] [Related]
2. CT-Based Radiomic Signature as a Prognostic Factor in Stage IV
Li H; Zhang R; Wang S; Fang M; Zhu Y; Hu Z; Dong D; Shi J; Tian J
Front Oncol; 2020; 10():57. PubMed ID: 32133282
[No Abstract] [Full Text] [Related]
3. Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non-small cell lung cancer.
Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Zhang Z; Ding L; Wu N; Zhao S
Thorac Cancer; 2021 Sep; 12(17):2388-2399. PubMed ID: 34288491
[TBL] [Abstract][Full Text] [Related]
4. Radiomic-signature changes after early treatment improve the prediction of progression-free survival in patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.
Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Zhang Z; Ding L; Wu N; Zhao S
Acta Radiol; 2023 Mar; 64(3):1194-1204. PubMed ID: 35971221
[TBL] [Abstract][Full Text] [Related]
5. Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer.
Jain P; Khorrami M; Gupta A; Rajiah P; Bera K; Viswanathan VS; Fu P; Dowlati A; Madabhushi A
Front Oncol; 2021; 11():744724. PubMed ID: 34745966
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a Radiomic Signature Developed in a General NSCLC Cohort for Predicting Overall Survival of ALK-Positive Patients With Different Treatment Types.
Huang L; Chen J; Hu W; Xu X; Liu D; Wen J; Lu J; Cao J; Zhang J; Gu Y; Wang J; Fan M
Clin Lung Cancer; 2019 Nov; 20(6):e638-e651. PubMed ID: 31375452
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer.
Xu J; Wang P; Li Y; Shi X; Yin T; Yu J; Teng F
Front Immunol; 2024; 15():1373330. PubMed ID: 38686383
[TBL] [Abstract][Full Text] [Related]
8. Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm.
Yang M; Shi L; Huang T; Li G; Shao H; Shen Y; Zhu J; Ni B
J Thorac Dis; 2023 Feb; 15(2):635-648. PubMed ID: 36910079
[TBL] [Abstract][Full Text] [Related]
9. Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors.
Wang TW; Chao HS; Chiu HY; Lu CF; Liao CY; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
Transl Oncol; 2024 Jan; 39():101826. PubMed ID: 37984256
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of UTE-MRI-based radiomics model for prediction of histopathologic subtype of lung adenocarcinoma: in comparison with CT-based radiomics model.
Lee S; Lee CY; Kim NY; Suh YJ; Lee HJ; Yong HS; Kim HR; Kim YJ
Eur Radiol; 2024 May; 34(5):3422-3430. PubMed ID: 37840100
[TBL] [Abstract][Full Text] [Related]
11. MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery.
Cai M; Yao F; Ding J; Zheng R; Huang X; Yang Y; Lin F; Hu Z
Front Oncol; 2021; 11():749114. PubMed ID: 34970482
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With
Wang H; Chen YZ; Li WH; Han Y; Li Q; Ye Z
Front Genet; 2022; 13():772090. PubMed ID: 35281837
[No Abstract] [Full Text] [Related]
13. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma.
Bao D; Zhao Y; Liu Z; Zhong H; Geng Y; Lin M; Li L; Zhao X; Luo D
Discov Oncol; 2021; 12(1):63. PubMed ID: 34993528
[TBL] [Abstract][Full Text] [Related]
15. Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer.
Chen BT; Jin T; Ye N; Mambetsariev I; Wang T; Wong CW; Chen Z; Rockne RC; Colen RR; Holodny AI; Sampath S; Salgia R
Front Oncol; 2021; 11():621088. PubMed ID: 33747933
[No Abstract] [Full Text] [Related]
16. Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer.
Shi X; Wang P; Li Y; Xu J; Yin T; Teng F
Thorac Cancer; 2024 Mar; 15(9):738-748. PubMed ID: 38376861
[TBL] [Abstract][Full Text] [Related]
17. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
Front Oncol; 2021; 11():603882. PubMed ID: 33738250
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
19. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
[TBL] [Abstract][Full Text] [Related]
20. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
